Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

OCEA Ocean Biomedical Inc

0,6131

0,0241 (4,09%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Notice of Effectiveness (effect)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
NOTICE OF EFFECTIVENESS

Effective Date:	June 22, 2023 4:30 P.M.
Form:	S-1

CIK:	0001869974
Company Name:	Ocean Biomedical, Inc.
File Number:	333-271392

Ocean Biomedical (NASDAQ:OCEA)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Ocean Biomedical Charts.

Ocean Biomedical (NASDAQ:OCEA)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Ocean Biomedical Charts.

News Ocean Biomedical, Inc.

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Freitag 22 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter
Dienstag 22 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses
Dienstag 1 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
Dienstag 27 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 23 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Freitag 23 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 23 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024
Mittwoch 5 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Donnerstag 30 Mai 2024 (7 Monate vor) • GlobeNewswire Inc.

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Donnerstag 16 Mai 2024 (7 Monate vor) • GlobeNewswire Inc.

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
Mittwoch 24 April 2024 (8 Monate vor) • GlobeNewswire Inc.

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
Donnerstag 28 März 2024 (9 Monate vor) • GlobeNewswire Inc.

Weitere Ocean Biomedical, Inc. News-Artikel

Deutsche Lufthansa

Financial Select Sector

Gold vs US Dollar

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen